mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.4 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.4 |
mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.4 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.4 |
mRNA |
MLN2480 |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.4 |
mRNA |
C6-ceramide |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.4 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |